Zuckerman Investment Group LLC Makes New $269,000 Investment in Oscar Health, Inc. (NYSE:OSCR)

Zuckerman Investment Group LLC purchased a new position in Oscar Health, Inc. (NYSE:OSCR) in the fourth quarter, Holdings Channel.com reports. The firm purchased 20,000 shares of the company’s stock, valued at approximately $269,000.

Other hedge funds have also recently made changes to their positions in the company. JPMorgan Chase & Co. boosted its holdings in Oscar Health by 348.7% in the fourth quarter. JPMorgan Chase & Co. now owns 10,360,529 shares of the company’s stock worth $139,246,000 after purchasing an additional 8,051,379 shares during the last quarter. BIT Capital GmbH boosted its stake in shares of Oscar Health by 5,711.6% in the 4th quarter. BIT Capital GmbH now owns 4,473,853 shares of the company’s stock worth $60,129,000 after buying an additional 4,396,872 shares during the last quarter. Hennessy Advisors Inc. boosted its stake in shares of Oscar Health by 550.3% in the 4th quarter. Hennessy Advisors Inc. now owns 4,188,400 shares of the company’s stock worth $56,292,000 after buying an additional 3,544,300 shares during the last quarter. Clearbridge Investments LLC purchased a new stake in Oscar Health during the fourth quarter valued at $19,088,000. Finally, American Century Companies Inc. lifted its holdings in Oscar Health by 185.6% in the fourth quarter. American Century Companies Inc. now owns 1,285,204 shares of the company’s stock valued at $17,273,000 after acquiring an additional 835,144 shares during the period. 75.70% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Separately, Wells Fargo & Company cut shares of Oscar Health from an “overweight” rating to an “equal weight” rating and lowered their price objective for the stock from $20.00 to $16.00 in a research note on Thursday, March 13th. Two research analysts have rated the stock with a sell rating, three have given a hold rating, two have issued a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, Oscar Health presently has a consensus rating of “Hold” and a consensus price target of $20.21.

Oscar Health Trading Up 7.3 %

Shares of NYSE:OSCR opened at $12.58 on Thursday. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.26. The company has a market capitalization of $3.15 billion, a PE ratio of -628.69 and a beta of 1.75. Oscar Health, Inc. has a 12-month low of $11.47 and a 12-month high of $23.79. The business’s fifty day simple moving average is $14.16 and its 200-day simple moving average is $15.48.

Oscar Health (NYSE:OSCR) last issued its earnings results on Tuesday, February 4th. The company reported ($0.62) EPS for the quarter, missing analysts’ consensus estimates of ($0.55) by ($0.07). Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. As a group, equities research analysts predict that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.

Oscar Health Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.